Products

Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rabbit Anti-Chikungunya Virus E3 Polyclonal Antibody

Cat. No.VD11Y612

Product TypeVeterinary Antibodies

Size

Inquiry Now Add to Inquiry List

Product Overview

BioVenic rabbit anti-Chikungunya virus E3 polyclonal antibody can be used in WB and IF to help researchers detect or develop diagnosis assays of Chikungunya virus infection.

Specifications

Application WB; IF

Clonality Polyclonal Antibody

Classification Primary Antibody

Clone N29Y48

Host Rabbit

Target Species Virus

Species Reactivity Virus

Specificity Chikungunya Virus E3

Isotype IgG

Immunogen Recombinant Chikungunya virus E3.

Purification Purified by antigen-affinity chromatography

Concentration 1.23 mg/mL

Conjugation Unconjugated

Preservative and Stabilizer 0.025% ProClin 300, 20% Glycerol

Buffer 1X Phosphate buffered saline, pH 7

Physical State Liquid

Target Information

Assembly protein E3 is a protein found in Chikungunya virus (CHIKV) that may be related to virus assembly. Understanding and studying E3 will help explore the pathogenesis of CHIKV.

Target Chikungunya Virus E3

Target Synonym Assembly protein E3

UniProt ID Q5WQY5

Shipping and Storage

This product is shipped with dry ice. Store at -20°C on receipt (up to 12 months). Avoid repeated freezing and thawing as this may denature the antibody.

Documents

Datasheet

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

Passos, Gabriel Felipe Silva, et al. "Computer-aided design, synthesis, and antiviral evaluation of novel acrylamides as potential inhibitors of E3-E2-E1 glycoproteins complex from chikungunya virus." Pharmaceuticals 13.7 (2020): 141.